Stress Management and Resiliency Training Program for Parkinson's Disease

NCT04903769 | Completed

• 1 other identifier: 663519
• Study Type: interventional
• Target: 49
• Locations: 1 country
• Sites: 1

Brief Summary

SMART-PD is an 8-session program designed to decrease the physiological, emotional, cognitive and behavioral effects of stress in participants with Parkinson's disease and their caregivers by teaching cognitive-behavioral techniques and relaxation skills to help participants learn to elicit the relaxation response, alter cognitive appraisals, improve healthy lifestyle behaviors and access social support. The SMART program has been shown to be effective for reducing mental health symptoms such as depression and anxiety as well as physical symptoms such as pain and in promoting positive health behaviors.

Conditions

Parkinson Disease

Outcome Measures

Primary Outcomes (10)

• Enrollment and participation

  The number of participants who enroll and fully participate in the program will be used to measure the feasibility of using SMART-PD for patients with Parkinson's disease and their caregivers.

  One year

• SMART Group Feedback Form

  Designed to assess the accessibility of the SMART-PD program, The SMART Group Feedback form contains six Likert-scale questions such as, "On a 10-point scale, how would you rate the following items: helpfulness/effectiveness of SMART group" and four open-ended questions such as, "What has been the most helpful part of the group for you?"

  Eight weeks

• Change from Baseline General Quality of Life at 1-week post-intervention

  The Short Form Health Survey (SF-36) is a quality of life measure that assesses eight aspects of health through the use of 36 multiple choice, yes/no, and Likert-scale items. An example question is, "Compared to one year ago, how would you rate your health in general now?" The SF-36 consists of eight scales (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health). Scores are converted into z-scores with a scale of 0-100 with 0 indicating the greatest level of disability and 100 the least.

  1-week post-intervention

• Change from Baseline Parkinson's disease Quality of Life at 1-week post-intervention

  The Parkinson's Disease Quality of Life Questionnaire (PDQ-39) consists of 39 Likert-scale questions asking how often in the last month the participant experienced something due to having Parkinson's disease. An example question is, "Had difficulty doing leisure activities which you would like to do?" with response options for all questions being "never", "occasionally", "sometimes", "Often", and "always or cannot do at all". The overall score from the PDQ-39 can be used for a global assessment, and scores can also be broken down into the following individual scales: mobility, activities of daily living, emotional well-being, stigma, social support, cognitions, communications and bodily discomfort.

  1-week post-intervention

• Change from Baseline Healthy Lifestyle Behaviors at 1-week post-intervention

  The Lifestyle Profile II contains 52 Likert-scale items pertaining to healthy lifestyle behaviors in the areas of healthy eating, physical activity, spirituality, stress management, health responsibility, and interpersonal relations. Respondents are asked to indicate the frequency with which they engage in behaviors with the response options of "Never", "Sometimes", "Often", and "Routinely". An example question is, "Take some time for relaxation each day." Scores range from 52-208 and fall into the categories of poor (52-90), moderate (91-129), good (130-168), an excellent (169-208).

  1-week post-intervention

• Change from Baseline Caregiver Burden at 1-week post-intervention

  The Zarit Burden Interview Short Form (ZBI-12) is designed to measure caregiver burden and consists of 12 Likert-scale items that ask respondents to if they feel a certain way "Never", "Rarely", "Sometimes", "Quite Frequently" or "Nearly Always". An example question is, "That because of the time you spend with your relative that you don't have enough time for yourself?" Scores range from 0-48 and are grouped into the categories of mild burden (0-10), mild to moderate burden (10-20), and high burden (\>20).

  1-week post-intervention

• Change from Baseline cognitive functioning at 1-week post-intervention

  The Montreal Cognitive Assessment (MoCA) is a rapid screening instrument for mild cognitive dysfunction. It assesses different cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation. Examples of questions include drawing a clock at ten past eleven and serial subtraction starting at 100. Scores on the MoCA range form 0-30 with a score of 26 or higher generally considered normal.

  1-week post-intervention

• Change from Baseline Coping at 1-week post-intervention

  Ways of Coping is a 66 Likert-scale item instrument that assesses behaviors used to cope with everyday stressful encounters. Response options are "Not Used", "Used Somewhat", "Used Quite A Bit", and "Used A Great Deal". Respondents are asked to describe a stressful situation they experienced in the past week and to respond to each item asking to what extent they used that way of coping in that situation. Examples of items are, "Turned to work or substitute activity to take my mind off things" and "Found new faith". The items comprise eight scales: confrontive coping, distancing, self-controlling, seeking social support, accepting responsibility, escape-avoidance, planful problem solving, and positive reappraisal.

  1-week post-intervention

• Change from Baseline Depression Symptoms at 1-week post-intervention

  The Patient Health Questionnaire (PHQ-9) is used to measure depressive symptoms. The nine Likert-scale items have response options of, "Not at all", "Several days", "More than half the days", and "Nearly every day" and include questions such as, "Little interest or pleasure in doing things" and "Poor appetite or overeating." Scores range from 0-27 with 0 indicating no depression and five bands of scores ranges indicating minimal (1-4), mild (5-9), moderate (10-14), moderately severe (15-19), and severe depression (20-27).

  1-week post-intervention

• Change from Baseline Anxiety Symptoms at 1-week post-intervention

  The Generalized Anxiety Disorder (GAD-7) consists of seven Likert-scale items designed to measure anxiety. Response options are, "Not at all", "Several Days", "More than half the days", and "Nearly every day" and item examples are, "Trouble relaxing" and "Becoming easily annoyed or irritated". Scores range form 0-21 with scores of 8 or higher indicating a probable anxiety disorder.

  1-week post-intervention

Study Arms (1)

Parkinson's Patients and Caregivers

OTHER

Will participate in the 8-session SMART-PD program as a participant with Parkinson's disease or as a caregiver of a participant with Parkinson's disease

Behavioral: Stress Management and Resiliency Training Program for Parkinson's Disease (SMART-PD)

Interventions

Stress Management and Resiliency Training Program for Parkinson's Disease (SMART-PD) BEHAVIORAL

SMART-PD is a manualized intervention that teaches cognitive-behavioral techniques and relaxation skills to help participants learn to elicit the relaxation response, alter cognitive appraisals, improve healthy lifestyle behaviors (i.e., sleep, nutrition, physical activity) and access social support.

Parkinson's Patients and Caregivers

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Diagnosis of Parkinson's Disease within the past three years or caregiver of someone with a recent diagnosis of Parkinson's disease
• Ability to participate in 8 weekly program sessions via Microsoft Teams or in-person (as available)
• Ability to provide informed consent

You may not qualify if:

• Previous participation in the SMART program

Sponsors & Collaborators

• Stony Brook University: lead
• Parkinson's Disease Foundation: collaborator

Study Sites (1)

Stony Brook Medical Center

Stony Brook, New York, 11794, United States

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases

Study Officials

• Adam Gonzalez, PhD

  Stony Brook Medical Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor of Psychiatry & Behavioral Health

Model Details: All participants will receive the SMART-PD intervention and will take baseline and follow-up assessments to determine the impact of the program

Study Record Dates

• First Submitted: May 24, 2021
• First Posted: May 27, 2021
• Study Start: August 3, 2020
• Primary Completion: January 25, 2022
• Study Completion: January 25, 2022
• Last Updated: April 28, 2026

Record last verified: 2025-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)